Menopausal hormone therapy is being reevaluated in terms of its benefits and risks. The use of hormone replacement therapy, including estrogen and progesterone, appears to be increasing, despite concerns about potential harms, particularly for breast cancer survivors. Research and medical professionals are exploring personalized management approaches and weighing the advantages and disadvantages of hormone therapy as a menopause treatment.